May 13, 2025 01:00PM
May 13, 2025 01:00PM
May 1, 2025 01:31PM
Apr 21, 2025 06:36AM
Apr 4, 2025 04:36PM
Mar 13, 2025 07:01AM
Mar 4, 2025 09:05AM Alumis (ALMS) and ACELYRIN (SLRN) Reaffirm Strategic and Financial Rationale of Proposed Merger
Feb 21, 2025 07:21AM
Feb 12, 2025 12:51PM
Feb 6, 2025 04:16PM
Jan 7, 2025 08:30AM
Jan 7, 2025 06:51AM
Jan 7, 2025 01:45AM
Jan 6, 2025 04:00PM Acelyrin (SLRN) Announces Additional Phase 2 Data and Phase 3 Program Design for Lonigutamab in Thyroid Eye Disease
Dec 11, 2024 07:24AM
Dec 10, 2024 04:50PM
Dec 10, 2024 04:31PM
Dec 10, 2024 04:25PM
Nov 14, 2024 01:17PM
Nov 14, 2024 06:58AM
Nov 13, 2024 05:20PM Acelyrin, Inc. (SLRN) Tops Q3 EPS by 70c
Sep 25, 2024 07:19AM
Sep 10, 2024 07:07AM
Aug 19, 2024 08:20AM
Aug 14, 2024 11:02AM
Aug 14, 2024 09:25AM
Aug 14, 2024 08:15AM
Aug 14, 2024 06:13AM H.C. Wainwright Downgrades Acelyrin Inc (SLRN) to Neutral
Aug 13, 2024 04:57PM
Aug 13, 2024 04:49PM
Aug 13, 2024 04:00PM
Jul 8, 2024 06:13AM

341,965 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All